Invention Grant
- Patent Title: Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases
-
Application No.: US13343493Application Date: 2012-01-04
-
Publication No.: US08383112B2Publication Date: 2013-02-26
- Inventor: Ulf Eriksson
- Applicant: Ulf Eriksson
- Applicant Address: US NY New York
- Assignee: Ludwig Institute for Cancer Research
- Current Assignee: Ludwig Institute for Cancer Research
- Current Assignee Address: US NY New York
- Agency: Fox Rothschild LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C12P21/08 ; C07K16/22
Abstract:
The present invention provides materials and methods for modulating FATP expression and/or activity in vivo. The materials and methods have numerous diagnostic, prophylactic, and therapeutic applications for various diseases and conditions that are influenced by FATPs, or characterized by excessive or inadequate FATP expression or activity.
Public/Granted literature
- US20120114642A1 TARGETING VEGF-B REGULATION OF FATTY ACID TRANSPORTERS TO MODULATE HUMAN DISEASES Public/Granted day:2012-05-10
Information query
